Siegfried USA, LLC, located in New Jersey, has submitted an application to become an importer of specific controlled substances, as noted by the Drug Enforcement Administration (DEA). The company plans to import these substances to create active pharmaceutical ingredients for its clients, specifically using Phenylacetone to produce Amphetamine. Comments or objections regarding this application are invited by March 18, 2021, and requests for a hearing can also be made by this date. Final permit approval will align with conditions outlined under the relevant U.S. Code and does not permit the commercial import of drug forms approved or non-approved by the Food and Drug Administration (FDA).
Simple Explanation
Siegfried USA, LLC wants permission from the government to bring special ingredients into the country to make medicine for their customers. People can say if they think it's a good or bad idea by a certain date, but it's important that these ingredients are used safely and not for anything bad.